Muscle weakness after repeated injection of botulinum toxin type A evaluated according to bite force measurement of human masseter muscle

Dermatologic Surgery

Volumn 35, Issue 12, 2009, Pages 1902-1907

  Kim, Ki Seo ^a   Byun, Young Sub ^a   Kim, Yong Jeong ^b   Kim, Seong Taek ^a  

^a Yonsei University College of Dentistry   (South Korea)

^b TUFTS UNIVERSITY SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADULT; ARTICLE; CLINICAL ARTICLE; CONVALESCENCE; FEMALE; FOLLOW UP; FORCE; HUMAN; MALE; MASSETER MUSCLE; MASTICATION; MUSCLE HYPERTROPHY; MUSCLE WEAKNESS; PREDICTION; PRIORITY JOURNAL; RELIABILITY; REPEATED DRUG DOSE; REPRODUCIBILITY;

EID: 72349089530     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2009.01319.x     Document Type: Article

References (21)

1. Jankovic J, Brin MF. Therapeutic uses of botulinum toxin. N Engl J Med 1991 324 : 1186 1194.
2. Simpson LL. Botulinum toxin: a deadly poison sheds its negative image. Ann Intern Med 1996 125 : 616 617.
3. Carruthers JD, Carruthers JA. Treatment of glabellar frown lines with C. botulinum-A exotoxin. J Dermatol Surg Oncol 1992 18 : 17 21.
4. Blitzer A, Brin MF, Keen MS, et al. Botulinum toxin for the treatment of hyperfunctional lines of the face. Arch Otolaryngol Head Neck Surg 1993 119 : 1018 1022.
5. Carruthers JA, Lowe NJ, Menter MA, et al. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol 2002 46 : 840 849.
6. Blitzer A, Binder WJ, Aviv JE, et al. The management of hyperfunctional facial lines with botulinum toxin. A collaborative study of 210 injection sites in 162 patients. Arch Otolaryngol Head Neck Surg 1997 123 : 389 392.
7. Clark GT. The management of oromandibular motor disorders and facial spasms with injections of botulinum toxin. Phys Med Rehabil Clin N Am 2003 14 : 727 748.
8. Moore AP, Wood GD. The medical management of masseteric hypertrophy with botulinum toxin type A. Br J Oral Maxillofac Surg 1994 32 : 26 8.
9. To EW, Ahuja AT, Ho WS, et al. A prospective study of the effect of botulinum toxin A on masseteric muscle hypertrophy with ultrasonographic and electromyographic measurement. Br J Plast Surg 2001 54 : 197 200.
10. Choe SW, Cho WI, Lee CK, et al. Effects of botulinum toxin type A on contouring of the lower face. Dermatol Surg 2005 31 : 502 507 discussion 507.
11. Kim NH, Chung JH, Park RH, et al. The use of botulinum toxin type A in aesthetic mandibular contouring. Plast Reconstr Surg 2005 115 : 919 930.
12. Kim HJ, Yum KW, Lee SS, et al. Effects of botulinum toxin type A on bilateral masseteric hypertrophy evaluated with computed tomographic measurement. Dermatol Surg 2003 29 : 484 489.
13. Park MY, Ahn KY, Jung DS. Botulinum toxin type A treatment for contouring of the lower face. Dermatol Surg 2003 29 : 477 483.
14. Kim JH, Shin JH, Kim ST, et al. Effects of two different units of botulinum toxin type a evaluated by computed tomography and electromyographic measurements of human masseter muscle. Plast Reconstr Surg 2007 119 : 711 717.
15. Yu CC, Chen PK, Chen YR. Botulinum toxin a for lower facial contouring: a prospective study. Aesthet Plast Surg 2007 31 : 445 451 discussion 452.
16. Alam M, Dover JS, Klein AW, et al. Botulinum a exotoxin for hyperfunctional facial lines: where not to inject. Arch Dermatol 2002 138 : 1180 1185.
17. Ahn KY, Kim ST. The change of maximum bite force after botulinum toxin type a injection for treating masseteric hypertrophy. Plast Reconstr Surg 2007 120 : 1662 1666.
18. Borodic GE, Ferrante R, Pearce LB, et al. Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injections. Mov Disord 1994 9 : 31 9.
19. Borodic GE, Ferrante R. Effects of repeated botulinum toxin injections on orbicularis oculi muscle. J Clin Neuroophthalmol 1992 12 : 121 127.
20. Rzany B, Dill-Müller D, German-Austrian Retrospective Study Group, et al. Repeated botulinum toxin A injections for the treatment of lines in the upper face: a retrospective study of 4,103 treatments in 945 patients. Dermatol Surg 2007 33 : S18 25.
21. Oshima M, Middlebrook JL, Atassi MZ. Antibodies and T cells against synthetic peptides of the C-terminal domain (Hc) of botulinum neurotoxin type A and their cross-reaction with Hc. Immunol Lett 1998 60 : 7 12.